Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening the way for life-saving anti-viral vaccines to reach remote and impoverished regions of the world.
The new method combines the active ingredients in existing vaccines with a sugary gel, where they remain viable for eight weeks or more, even at elevated temperatures.
The method creates light, durable, and compact doses that would be ideal for shipping Ebola vaccine, for example, to affected regions of Africa, the researchers say. The process adds only marginal cost to preparing a vaccine and eliminates almost all the cost of transporting it – which can account for 80 per cent of the total cost of inoculation.
Combining the vaccines and the sugars – pullulan and trehalose – is almost as simple as stirring cream and sugar into coffee, the researchers say. The storage technology was created by chemical engineers at McMaster, who had already demonstrated its effectiveness in other applications, such as an edible coating that can prolong the shelf life of fruits and vegetables.
To apply the technology to vaccines, the engineers collaborated with health sciences colleagues across campus who specialize in virology and immunology. Their work is published today in the journal Scientific Reports and also appeared on the front page of the Globe and Mail newspaper.
“This, to us, is the ultimate application of this technology,” said the paper’s lead author Vincent Leung, an assistant professor of Chemical Engineering. “To imagine that something we worked on in the lab could one day be used to save people’s lives is very exciting.”
The invention is significant because it can replace the cumbersome “cold chain” – constant storage at temperatures between 2C and 8C – which is currently necessary to keep anti-viral vaccines viable. Maintaining the cold chain is a significant barrier to inoculating people in remote or poor regions of the world, where the infrastructure to refrigerate and transport vaccines smoothly may not be available.
“You can spend all kinds of money developing a vaccine, but if it is deactivated by high temperature an hour before you can give it to someone, it doesn’t matter,” says co-author Ali Ashkar, a professor of Pathology and Molecular Medicine specializing in immunology.
The cold-chain challenge is so great, the researchers say, that in some regions, vaccines must be transported by camels bearing solar-powered mini-refrigerators. There are some populations that never receive vaccines.
“If you can’t get vaccines to the places where people need them, there’s no point in having them,” says co-author Matthew Miller, an assistant professor in the Department of Biochemistry and Biomedical Sciences whose laboratory specializes viral pathogens.
Not being able to get vaccines to isolated areas makes it impossible to eradicate deadly viruses. Unchecked, such viruses can devastate local populations and reach exposed pockets in more populated countries where religious, cultural or other concerns have diminished the proportion of vaccinated individuals. Such a scenario has recently been playing out in in a measles outbreak in the US northwest and Vancouver, BC.
The new vaccine-storage method suspends the active components of a vaccine in a tiny one-dose container filled with a sugar-gel combination that dries to seal in the vaccine. Later, clinicians reconstitute the vaccine with water and administer it to patients as they ordinarily would.
“Often, complex problems have simple solutions. It just takes the right team,” says Miller. “The best research comes from merging fields, when you do something with someone else that you couldn’t do alone.”
The researchers have proven the method to be viable using two sample vaccines – influenza virus and herpes simplex virus – to inoculate and test mice by exposing them to the viruses because the immune response of mice is similar to that of humans. The materials in the storage medium are already approved by the US Food and Drug Administration, simplifying the path to commercialization.
“All the pieces are ready to go,” says co-author Carlos Filipe, chair of Chemical Engineering at McMaster. “It’s actually quite simple compared to the technology required to create a vaccine itself.”
The researchers are working with a commercial partner to get the technology to market.
The Latest on: Vaccine storage
via Google News
The Latest on: Vaccine storage
- Northland children betrayed as vaccines expireon June 21, 2019 at 6:18 pm
and an extra 5000 Pfizer vaccines also purchased, now sit in storage slowly expiring. Northland has already had one new case of MenW this year, and the coldest part of winter and the highest ... […]
- Healthcare Cold Chain Logistics Market Estimated To Perceive Heightened Growth by 2023 - Study Report by MRFRon June 20, 2019 at 4:35 am
Ongoing intensive research & development activities, as well as the growth of the biomedical field and drug discovery, has increased the demand for biopharmaceuticals and vaccines. Proper storage ... […]
- Measles Vaccination in Other Countries: A Different Viewon June 19, 2019 at 9:22 am
Expensive vaccines, supply shortages, lack of trained health workers, unreliable transportation systems and storage facilities without refrigeration all pose challenges for poor countries in their ... […]
- Veterinary Vaccines Market Growth Backed by the Increased Adoption Rate of Pets in the Worldon June 19, 2019 at 6:11 am
However, increasing costs for the storage of vaccines and rising prices of meat that is in turn promoting the adoption of vegetarian diets are the major factors that may hamper the growth of the ... […]
- Patients warned following vaccine bungleon June 19, 2019 at 3:36 am
“Storage of vaccinations is a serious matter,” Dr Nespolon said, highlighting that RACGP standards clearly explain the need to keep vaccines within an optimal temperature range. Any patients of the ... […]
- Thousands of Australians exposed to expired vaccines, authorities warnon June 18, 2019 at 11:54 pm
... s unfortunate that expired vaccines have been given and that vaccination records and vaccine storage in fridges appears to have been compromised in one General Practice,” Robert Booy ... […]
- France leads the world in mistrust of vaccineson June 18, 2019 at 9:04 pm
The World Health Organization says making vaccines mandatory is one of the best ways to boost ... brutally punched his dog as it cowered in fear on the sofa as he is... The storage of information, or ... […]
- Vaccination reactionson June 14, 2019 at 2:57 pm
“There are some things we can do to help reduce risk for reactions, and these include proper vaccine storage, handling and administration. How we store vaccine (at proper temperature), mix it up (if ... […]
- Veterinary/Animal Vaccines Market Report Competition by Manufacturers, Type and Application, Growth and Opportunities 2026on June 14, 2019 at 11:29 am
Veterinary vaccines increase immunity of animals by improving animal ... However, persistent economic slowdown, rising costs of storage and maintenance and the increase in the vegetarian population ... […]
- Emergent BioSolutions gets FDA approval for cholera vaccine storage changeon June 4, 2019 at 2:00 pm
The U.S. Food and Drug Administration granted approval Tuesday of the Prior Approval Supplement (PAS) submitted by to Gaithersburg-based Emergent BioSolutions Inc. for its oral cholera vaccine, ... […]
via Bing News